Navigation Links
Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
Date:3/7/2011

f central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a CRL from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company completed an end-of-review meeting with the FDA in late December 2010.  

The Company believes it has a clear understanding of the issues outlined in the CRL, is developing and executing a plan to address these issues, and currently projects a resubmission of the AZ-004 NDA in July 2011.  

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looki
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
2. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
3. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
4. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
5. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
6. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
7. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
8. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
9. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
10. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
11. Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive ... services are delivered, leading to better outcomes, decreased ... The market for mHealth solutions is still in ...
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors ... week at the 3M Championship Champions Tour event near ... in Blaine . Stryker is the official joint ... Starting Friday, August 1 st through Sunday, August ... Mobility Zone; an on-site joint health destination located in the Pioneer ...
Breaking Medicine Technology:mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
(Date:7/30/2014)... ,, , ... ... ... ... passed. , For the study, published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led ...
(Date:7/30/2014)... VA (PRWEB) July 30, 2014 The ... 2014-2015 Board of Directors. Sandra Aiken Chack will serve ... month at the EDNF 2014 Annual Learning Conference in ... Foundation has an ambitious agenda ahead of us. From ... Care & Research at the Greater Baltimore Medical Center ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help consumers ... Quote tool on its website, LTCconsumer.com , announced Nathan ... free and unlimited. , The Instant Quote tool ... age, gender, and state of residence – and delivers a ... enter any contact information to get started). There is no ...
(Date:7/30/2014)... The American Telemedicine Association (ATA) ... Cochran (R-MS) and Roger Wicker (R-MS) for their ... under Medicare, Medicaid and Federal Communications Commission programs. ... introduced the Telehealth Enhancement Act as S. 2662, ... 3306, introduced by Rep. Gregg Harper (R-MS) which ...
(Date:7/30/2014)... OR (PRWEB) July 30, 2014 ... evaluating the quality of care that their practitioners ... CEO, Mr. Andrew Rowe, discussed the importance of ... to improve physician performance and quality of care. ... effective practitioner evaluation, Mr. Rowe elaborated on setting ...
Breaking Medicine News(10 mins):Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3
... , WASHINGTON, Dec. 10 The Community Oncology Alliance (COA) ... may face closing their practices if critical Medicare reimbursement fixes ... of health care reform. , "Current health reform legislation before ... substantial cuts coming in January to cancer care," said Patrick ...
... , Helps PSI, DFID and USAID highlight progress ... Dec. 10 Emmy Award winning actress and PSI (Population ... donors and individuals who have contributed to the substantial decline ... past six years Zimbabwe has seen a dramatic reduction in ...
... tuberculosis bacteria use to coerce disease-fighting cells to switch ... the airways and other surfaces to protect and defend ... helping create tubercles: the small, rounded masses characteristic of ... numbers and spread to other locations. By ...
... drug developed to prevent the death of nerve cells after ... cells healthy and intact, an international team led by a ... Breast Cancer Research . Prof. Malka Cohen-Armon of ... a member of a family of phenanthridine derivatives developed ...
... of Medicine have developed a new model of skin cancer ... Src kinase is activated in human skin-cancer samples. ... in human squamous cell carcinomas of the skin. We modeled ... a member of Src family of proteins, in mouse skin," ...
... , "...it is also true that security does not exist ... water, or the medicine they need to survive ." - ... Day -- At his Nobel Peace Prize acceptance speech in Oslo, Norway, ... to medicines for all people as a prerequisite to security. The ...
Cached Medicine News:Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 2Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 3Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 4Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 2Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 3Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 3Health News:Finding the Achilles' heel of cancer 2Health News:New model of skin cancer provides insights on second-most common type of cancer 2Health News:GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 2
... Fast and easy voice access to information ... SoundAdvice is easy and intuitive, enabling you ... your keyboard. With the VoiceBox Voice Information ... about hundreds of subjects and topics and ...
... hand-held potential vision tester measures retinal acuity ... Potential vision testing requires two related ... RAM (formerly known as the Illuminated Near ... with a pinhole disc and hinged lens). ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: